Report #2829071

Received Mar 3, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Male
Age: Age unknown
State: CT
Recovered: Recovered
Vaccinated: Dec 1, 2023
Onset: Feb 1, 2025
Days to onset: 428
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HEP	HEP B (HEPLISAV-B)	DYNAVAX TECHNOLOGIES CORPORATION	1	—	—

Symptoms (2)

Incomplete course of vaccinationNo adverse event

Symptom narrative

Received First Dose in Dec 2023, But Has Not Had the Second Dose; Initial report received on 11-Feb-2025. A nurse reported that a male (age, race, and ethnicity not reported) received the first dose of HEPLISAV-B (hepatitis B vaccine) for hepatitis B immunization in Dec-2023 but has not had the second dose yet. No medical history or concomitant medications were reported. In Dec-2023, the patient received dose 1 of a hepatitis B vaccine HEPLISAV-B (lot number, expiration date, NDC number, route, and site not available). In Feb-2025, at the time of reporting the patient had not received the second dose yet. No adverse reactions were reported. The reporter declined to provide further information. Company Comment: The company assessed the event as non-serious.; Sender's Comments: The company assessed the event as non-serious.